Therefore, it could be considered as a promising adjuvant in the treatment of diabetes and its complications
PMID:25504085
SOCS1 can reduce the expression of SLC7A11, in addition to GSH levels, sensitizing cells to ferroptosis (Saint-Germain et al., 2017)
For reference, the pivotal trials enrolled adults with a body mass index of 30 kg/m or greater, or 27 kg/m or greater with at least one weight-related comorbid condition such as treated or untreated dyslipidemia or hypertension
In the U.S., about 6% of adults currently use GLP-1s, and 12% have used them in the past (2024 data) (Mozafariun 2025)
During your estimate, we will provide an expected schedule and keep you informed throughout the process to ensure your project is completed efficiently and on time